Rtw Investments, Llc Buys Baxter International Inc, Cerner Corp, Oyster Point Pharma Inc, Sells Bristol-Myers Squibb Company, Zimmer Biomet Holdings Inc, Sarepta Therapeutics Inc

• New Purchases: BAX, CERN, OYST, FREQ, DMTK, MGNX, ISEE, CLDX, ADAP, OSUR, TELA, XGN, GNMK, NEO, AMRS, RPTX, BWAY, ARYBU, LSACU, PROG, NARI,
• Added Positions: AXSM, TXG, IMVT, RLMD, TNDM, MYOK, NTRA, PTGX, MRTX, AXNX, AVDL, DRNA, ODT, BLU, CSTL, CTMX, ADVM, MASI, JNJ, PRQR, TWST,
• Reduced Positions: STAA, WVE, ARVN, VCEL, NSTG, AGEN, FIXX,
• Sold Out: BMY, ZBH, SRPT, GBT,

For the details of RTW INVESTMENTS, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/rtw+investments%2C+llc/current-portfolio/portfolio

1. Rocket Pharmaceuticals Inc (RCKT) - 16,812,491 shares, 10.21% of the total portfolio.
2. Alnylam Pharmaceuticals Inc (ALNY) - 1,681,645 shares, 7.23% of the total portfolio.
3. PTC Therapeutics Inc (PTCT) - 3,963,120 shares, 5.84% of the total portfolio. Shares added by 0.77%
4. Dicerna Pharmaceuticals Inc (DRNA) - 7,152,918 shares, 5.27% of the total portfolio. Shares added by 2.73%
5. Adverum Biotechnologies Inc (ADVM) - 6,790,027 shares, 4.11% of the total portfolio. Shares added by 2.39%

Rtw Investments, Llc initiated holding in Baxter International Inc. The purchase prices were between $78.66 and $94.14, with an estimated average price of $87.01. The stock is now traded at around $79.05. The impact to a portfolio due to this purchase was 2.42%. The holding were 969,370 shares as of .

Rtw Investments, Llc initiated holding in Cerner Corp. The purchase prices were between $60.71 and $73.85, with an estimated average price of $68.6. The stock is now traded at around $68.63. The impact to a portfolio due to this purchase was 2.35%. The holding were 1,182,409 shares as of .

Rtw Investments, Llc initiated holding in Oyster Point Pharma Inc. The purchase prices were between $27.86 and $35.93, with an estimated average price of $30.18. The stock is now traded at around $19.31. The impact to a portfolio due to this purchase was 1.6%. The holding were 1,909,360 shares as of .

Rtw Investments, Llc initiated holding in Frequency Therapeutics Inc. The purchase prices were between $14.65 and $24.9, with an estimated average price of $18.04. The stock is now traded at around $22.47. The impact to a portfolio due to this purchase was 1.46%. The holding were 2,161,486 shares as of .

Rtw Investments, Llc initiated holding in DermTech Inc. The purchase prices were between $10.39 and $15.38, with an estimated average price of $12.99. The stock is now traded at around $11.09. The impact to a portfolio due to this purchase was 1.1%. The holding were 2,855,765 shares as of .

Rtw Investments, Llc initiated holding in Macrogenics Inc. The purchase prices were between $5.2 and $29.12, with an estimated average price of $17.14. The stock is now traded at around $25.79. The impact to a portfolio due to this purchase was 1.01%. The holding were 1,245,816 shares as of .

Rtw Investments, Llc added to a holding in Axsome Therapeutics Inc by 57.49%. The purchase prices were between $49.87 and $98.69, with an estimated average price of $76.44. The stock is now traded at around $81.27. The impact to a portfolio due to this purchase was 1.45%. The holding were 1,658,316 shares as of .

Rtw Investments, Llc added to a holding in 10x Genomics Inc by 234.59%. The purchase prices were between $58.39 and $89.31, with an estimated average price of $77.42. The stock is now traded at around $122.62. The impact to a portfolio due to this purchase was 1.16%. The holding were 636,092 shares as of .

Rtw Investments, Llc added to a holding in Immunovant Inc by 29.17%. The purchase prices were between $13.87 and $28.44, with an estimated average price of $21.23. The stock is now traded at around $35.76. The impact to a portfolio due to this purchase was 0.91%. The holding were 5,717,182 shares as of .

Rtw Investments, Llc added to a holding in Relmada Therapeutics Inc by 50.41%. The purchase prices were between $31.59 and $49.98, with an estimated average price of $42.11. The stock is now traded at around $37.53. The impact to a portfolio due to this purchase was 0.64%. The holding were 1,480,852 shares as of .

Rtw Investments, Llc added to a holding in Tandem Diabetes Care Inc by 34.98%. The purchase prices were between $60.05 and $98.92, with an estimated average price of $79.5. The stock is now traded at around $108.34. The impact to a portfolio due to this purchase was 0.45%. The holding were 598,923 shares as of .

Rtw Investments, Llc added to a holding in Natera Inc by 20.77%. The purchase prices were between $26.36 and $49.86, with an estimated average price of $39.95. The stock is now traded at around $64.01. The impact to a portfolio due to this purchase was 0.38%. The holding were 1,529,128 shares as of .

Rtw Investments, Llc sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $54.82 and $64.09, with an estimated average price of $59.75.

Rtw Investments, Llc sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $89.63 and $137.4, with an estimated average price of $118.39.

Rtw Investments, Llc sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $93 and $171.7, with an estimated average price of $135.31.

Rtw Investments, Llc sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $48.73 and $81.82, with an estimated average price of $68.29.

Rtw Investments, Llc reduced to a holding in Staar Surgical Co by 54.28%. The sale prices were between $29.15 and $61.54, with an estimated average price of $40.57. The stock is now traded at around $55.35. The impact to a portfolio due to this sale was -0.54%. Rtw Investments, Llc still held 308,904 shares as of .

Rtw Investments, Llc reduced to a holding in WAVE Life Sciences Ltd by 29.48%. The sale prices were between $7.44 and $11.29, with an estimated average price of $9.41. The stock is now traded at around $15.84. The impact to a portfolio due to this sale was -0.43%. Rtw Investments, Llc still held 2,390,496 shares as of .

Rtw Investments, Llc reduced to a holding in Arvinas Inc by 49.52%. The sale prices were between $29.88 and $56.74, with an estimated average price of $42.5. The stock is now traded at around $26.18. The impact to a portfolio due to this sale was -0.32%. Rtw Investments, Llc still held 174,118 shares as of .